UK markets open in 14 minutes

Fulcrum Therapeutics, Inc. (FULC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.34-0.34 (-5.09%)
At close: 04:00PM EDT
6.24 -0.10 (-1.58%)
After hours: 07:37PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,510
2,805
6,342
19,163
8,823
-
Operating expenses
Research development
74,859
71,801
76,782
69,701
59,042
-
Selling general and administrative
40,209
41,668
41,694
30,516
21,392
-
Total operating expenses
115,068
113,469
118,476
100,217
80,434
-
Operating income or loss
-112,558
-110,664
-112,134
-81,054
-71,611
-
Total other income/expenses net
13,132
13,329
2,263
207
792
-
Income before tax
-99,426
-97,335
-109,871
-80,847
-70,819
-
Income from continuing operations
-99,426
-97,335
-109,871
-80,847
-70,819
-
Net income
-99,426
-97,335
-109,871
-80,847
-70,819
-
Net income available to common shareholders
-99,426
-97,335
-109,871
-80,847
-70,819
-
Basic EPS
-1.66
-
-2.44
-2.29
-2.79
-8.13
Diluted EPS
-1.66
-
-2.44
-2.29
-2.79
-8.13
Basic average shares
58,880
-
44,991
35,361
25,354
11,046
Diluted average shares
58,880
-
44,991
35,361
25,354
11,046